Sector
PharmaceuticalsOpen
₹0.23Prev. Close
₹0.24Turnover(Lac.)
₹0.54Day's High
₹0.25Day's Low
₹0.2352 Week's High
₹052 Week's Low
₹0Book Value
₹6.3Face Value
₹1Mkt Cap (₹ Cr.)
5.87P/E
0EPS
0Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 | Mar-2010 | Mar-2009 |
---|---|---|---|---|
Equity Capital | 24.45 | 24.45 | 24.15 | 12.08 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 140.97 | 137.53 | 136.88 | 133.83 |
Net Worth | 165.42 | 161.98 | 161.03 | 145.91 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 |
---|---|---|
Revenue | 268.04 | 272.66 |
yoy growth (%) | -1.69 | |
Raw materials | -179.16 | -180.06 |
As % of sales | 66.84 | 66.03 |
Employee costs | -11.99 | -10.29 |
Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 |
---|---|---|
Profit before tax | 6.9 | 25.15 |
Depreciation | -7.67 | -4.45 |
Tax paid | -2.9 | -7.85 |
Working capital | 19.82 | |
Other operating items |
Y/e 31 Mar | Mar-2012 | Mar-2011 |
---|---|---|
Growth matrix (%) | ||
Revenue growth | -1.69 | |
Op profit growth | -14.22 | |
EBIT growth | -22.21 | |
Net profit growth | -73.92 |
Particulars (Rupees in Crores.) | Mar-2008 |
---|---|
Gross Sales | 168.3 |
Excise Duty | 16.94 |
Net Sales | 151.36 |
Other Operating Income | 0 |
Other Income | 3.02 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,910.5 | 164.97 | 4,59,136.74 | 237.82 | 0.71 | 4,409.74 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 5,422.55 | 86.76 | 1,44,114.93 | 430 | 0.55 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,622.85 | 33.67 | 1,33,733.09 | 1,055.94 | 0.78 | 3,752.25 | 346.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,475.6 | 76.34 | 1,14,734.62 | 469 | 0.83 | 2,394 | 201.77 |
Dr Reddys Laboratories Ltd DRREDDY | 6,635.5 | 27.28 | 1,12,386.62 | 1,417.2 | 0.59 | 5,823.9 | 1,458.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
K Hari Babu
Whole-time Director
M S S V Satyanarayana
Company Secretary
Vidya Sagar Soma
Director
A Siva Rami Reddy
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Anus Laboratories Ltd
Summary
The Company was incorporated in the year 1996 for manufacture of Bulk Active Pharma Ingredients and Intermediates for drug molecules and was promoted by Mr. K. Hari Babu. Mr. N.S. Walimbe joined as co-promoter in the year 1997.The Company was not having its own manufacturing facilities initially and utilized premises and production facilities of Dr. Curies Labs Limited for a period of two years till 1998 under leave and license agreement, which terminated in September, 1998. At this facility the Company has manufactured 2,4 Dichloro 5 Fluoro Acetophenone (DCFA) a drug intermediate for manufacture of Quinolones, which has supplied to Dr. Reddys Laboratories Limited and Aurobindo Pharma Limited.The company has engaged in manufacture of Basic & Advanced Intermediates and fine chemicals and are presently having manufacturing facilities for key intermediates like 2,4-Dichloro-5-Fluoro Acetophenone (DCFA) (an intermediate for synthesizing quinolone antibiotics like ciprofloxacin); Chlorohexanone (key intermediate in the manufacture of cardio vascular medicine) and Methyl-4 (4-Chloro 1 oxo butane) a, a Di-Methyl Acetate (an intermediate in the manufacture of Fexofenadine an anti allergic drug). In July 14, 1998, The company entered an agreement with Andhra Pradesh Industrial Development Corporation (APIDC) and Andhra Pradesh State Financial Corporation (APSFC) to purchase land, buildings and plant & machinery of M/s Jay Organics Limited situated at Survey No. 17, Chilakamarri Villag
Read More
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice